David K. Gaffney,
MD, PhD
Vice-Chair, Department of Radiation Oncology
Languages Spoken: English
David Gaffney, MD, PhD, is vice-chair and professor of radiation oncology at the University of Utah School of Medicine and Huntsman Cancer Institute. He is an HCI investigator and member of the Experimental Therapeutics program. His primary clinical interests are in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma. His main research interests are in clinical trial development, prognostic markers, and secondary cancers.
Dr. Gaffney is interested in clinical trials that improve survival and quality of life for cancer patients. He serves as chair of the Gynecologic Working Group for the Radiation Therapy Oncology Group (RTOG). The RTOG is a multi-institutional cooperative cancer research organization that conducts clinical trials. He is active in the Gynecologic Cancer Intergroup (a worldwide organization of clinical trial groups). He serves on a National Cancer Institute panel evaluating gynecologic clinical trials. Dr. Gaffney is the chair of the Clinical Cancer Investigation Committee at the University of Utah and Huntsman Cancer Institute. He serves as a Senior Editor for the International Journal of Gynecologic Cancer, and he is a member of multiple professional societies.
In addition, Dr. Gaffney is interested in radiation sensitizers, which are drugs that make cancer cells more sensitive to the effects of radiation therapy. Dr. Gaffney enjoys working with medical students and residents on a wide variety of projects.
Dr. Gaffney received his PhD in biochemistry from the Medical College of Wisconsin in 1990 and his MD from the same institution in 1992. He completed an internship at LDS Hospital in Salt Lake City, Utah, and a residency in radiation oncology at the University of Utah School of Medicine.
David Gaffney, MD, PhD, is vice-chair and professor of radiation oncology and Senior Director for Clinical Research at the Huntsman Cancer Institute. His main research interests are in clinical trial development, prognostic markers, radiation sensitizers, and secondary cancers. He is an active clinician and specializes in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma.
Dr. Gaffney is interested in clinical trials that improve survival and quality of life for cancer patients. He serves as a co-Chair for the National Cancer Institute Gynecologic Cancer Steering Committee and previously was chair of the Gynecologic Working Group for the Radiation Therapy Oncology Group (RTOG). He is a past chair of the American Brachytherapy Society and the Cervix Cancer Research Network. He is active in the Gynecologic Cancer Intergroup, a worldwide organization of clinical trial groups. He also chairs the Clinical Research Executive Committee at the Huntsman Cancer Institute and serves as a Senior Editor for the International Journal of Gynecologic Cancer, Gynecologic Oncology, and the American Journal of Clinical Oncology, and Brachytherapy.
In addition, Dr. Gaffney is interested in radiation sensitizers, which are drugs that make cancer cells more sensitive to the effects of radiation therapy. Dr. Gaffney enjoys working with medical students and residents on a wide variety of projects.
Dr. Gaffney received his PhD in biochemistry from the Medical College of Wisconsin in 1990 and his MD from the same institution in 1992. He completed an internship at LDS Hospital in Salt Lake City, Utah, and a residency in radiation oncology at the University of Utah School of Medicine.
Clinical Locations
801-581-2396
Specialties
Board Certification and Academic Information
| Academic Departments | Radiation Oncology
-
Professor |
| Board Certification | American Board of Radiology (Radiation Oncology) |
| Cancer Center Programs | Experimental Therapeutics |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.8/ 5
Care provider spoke using clear language
4.9/ 5
Care provider's explanation of condition/problem
4.9/ 5
My confidence in care provider
4.9/ 5
Care provider's effort to include me in decisions
4.8/ 5
Wait time at clinic
4.6/ 5
Time care provider spent with me
4.7/ 5
Care provider's concern for questions & worries
4.8/ 5
Care provider's friendliness and courtesy
4.9/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
May 15, 2019
Thanks Dr Gaffney for helping me understand my CAT Scan.
UofU Patient
April 15, 2019
I went from being so scared and unsure about my health,to feeling like everything was going to workout. wish everyone could experience how wonderful the Huntsmen Hospital is.
UofU Patient
March 25, 2019
Dr. Gaffney is a great doctor with a wonderful sense of humor. He is very caring and professional.
UofU Patient
March 18, 2019
Dr. Gaffney and his team went to Harvard in bedside manner. They made navigating a tough experience almost enjoyable. Their distraction efforts made you smile while they still were reassuring about the level of expertise they were using to set you up to go through radiation. Always smiling and comforting. You hardly knew that you were going to have a tough few weeks. My thanks to Mark, Dahne, Trisha (I think) and all of the team. I have a great deal of confidence about the next few weeks. _____ __________
UofU Patient
February 14, 2019
Wonderful Doctor and staff
UofU Patient
January 12, 2019
I am grateful for the staff and doctors of the HCI
UofU Patient
November 19, 2018
always have a great experience with everyone at Huntsman
UofU Patient
September 24, 2018
They were all so very understanding. Spent a lot of time with me.
UofU Patient
June 19, 2018
You are the only doctor I've had who makes the pelvic exam painful and causes bleeding. I've been doing this all my life, so I know it doesn't have to be this way. I tried to tell you before, but your nurse brushed it off and this visit showed that you didn't make any changes. You have my complete confidence as a radiation oncologist, and I feel that you are friendly and easy to talk to. But I am glad that after 5 years you won't be giving me another pelvic.
UofU Patient
May 28, 2018
very well done
UofU Patient
April 25, 2018
I had questions that I did not feel like I had time to ask...which is my fault, but the appointment felt rushed and a bit chaotic as I had been overlooked and left waiting. It was just an off day. I am sure that my doctor would have addressed all of my concerns had I asked all of my questions.
UofU Patient
March 21, 2018
Dr. Gaffney was great, and his intern spent a lot of time with me. Andrew was the best care provider I've seen at Huntsman for taking time, making me feel comfortable, and letting me ask questions. Dr. Gaffney spent enough time to talk to me, answer questions and ask me questions, it just seemed like he was in a hurry. However, maybe his schedule is really tight. He is probably in high demand.
UofU Patient
March 04, 2018
I left the appointment feeling that I was in the best of hands. I so appreciate that those working at Huntsman are concerned about the whole person and also the effect that the diagnosis has upon those in the family.
UofU Patient
February 28, 2018
always concerned about answering any Questions I might have.
UofU Patient
January 08, 2018
love the Dr and staff, always nice and caring.
UofU Patient
December 20, 2017
Dr. Gaffney is a good listener and basically left the decision about the type of radiation up to me. I feel very confident in his and his staffs' abilities.
UofU Patient
December 01, 2017
Dr. Gaffney is fantastic. He is always willing to list to questions about plans for treatment and gives sound guidance as to why things need to progress at a certain rate. I know that he has my best interest at heart.
UofU Patient
November 25, 2017
I appreciate the time Dr Gaffney spent going over treatment options. Once we decided on a course of therapy they were able to work me up the same day! The entire team was very supportive and caring!
UofU Patient
November 07, 2017
Dr. Gaffney is great. He is very understanding and explains things appropriately. His nurse Ruth was very helpful and apologetic for my being rescheduled so many times.
UofU Patient
September 05, 2017
Dr Gaffney is always professional and very kind.
UofU Patient
July 31, 2017
Dr. Gaffney is always very informative, concerned, easy to talk with helpful. I always feel well cared for and informed under his care.
UofU Patient
July 14, 2017
I am on my follow up appointments, Dr and nursing staff are and have always been great, caring. makes a scary, upsetting situation better.
UofU Patient
June 18, 2017
amazing place
UofU Patient
May 13, 2017
Dr. Gaffney is the best there is!
UofU Patient
May 07, 2017
All were very kind.
UofU Patient
March 04, 2017
Impressed and felt immediately comfortable with both Dr. Ager and Dr. Gaffney.
UofU Patient
February 06, 2017
Dr. Gaffney is great. He seems genuine and caring.
UofU Patient
January 26, 2017
Dr. Gaffney and his technical staff are always extremely caring, considerate, informative and take care to answer all questions I might have as well as about my condition.
UofU Patient
January 22, 2017
Dr. Gaffney is a wonderful doctor and a caring person.
UofU Patient
December 18, 2016
Dr. Gaffney is a very kind and caring physician (and he went to Canoga Park High School!)
UofU Patient
December 17, 2016
Huntsman's Cancer Hospital is one that we would recommend to anyone. My Sister was very sick at her local hospital and David said to get her to Huntsmans. They were immediately on her case and found the cancer and got rid of it. Her life was saved.
UofU Patient
December 17, 2016
Electronic records about my visit last year contained completely false information.
UofU Patient
November 28, 2016
Always very kind, considerate and informed treatment
UofU Patient
October 22, 2016
Gaffney knows he's one of my faves!
UofU Patient
October 06, 2016
I will definitely recommend them and the facility.
UofU Patient
September 01, 2016
Dr. Gaffney has always been a pleasure to work with!
UofU Patient
August 03, 2016
Dr. Gaffney is personable and friendly. I find him easy to talk to.
UofU Patient
June 29, 2016
Dr. Gaffney made every effort to reduce the number of times I would have to travel from Kemmerer WY (my home) to Utah. He was able to schedule a visit to Radiation Oncology for simulation on same day as my initial visit to see him. He also informed my of the Hope House.
UofU Patient
June 27, 2016
Dr. Gaffney and his assistant a nurse practioner were excellent.
UofU Patient
May 24, 2016
I was very impressed with the amount of time that both Andrew and Dr. Gaffney spent with me, the concern they showed about my condition, and their patience in explaining the course of treatment and the available options.
UofU Patient
May 23, 2016
I appreciated Dr. Gaffney's explanations and concern for my welfare. He seemed sympathetic to my desire to get treatment going as soon as my Oncotype DX test was back. His office moved my simulation up when my Onco test came back sooner that I was told it would.
UofU Patient
March 01, 2016
A very good experience with Dr Gaffney and team. He was very aware of my history.
UofU Patient
February 23, 2016
Dr. Gaffney is the best, he sincerely cares and wants the best for patients.
UofU Patient
February 13, 2016
Drs. Gaffney and Francis were easy to talk with, personable and kind. They responded quickly to questions and requests, like providing me with the op report from my surgery.
UofU Patient
January 27, 2016
Everyone I dealt with was helpful and explained every process they were going to do in depth which puts the patient at ease.
UofU Patient
January 24, 2016
Dr. Gaffney and his resident Sam were really great. They made this anxiety ridden appointment as painless as they could. I appreciated that they moved me from an examination room to a consultation room to discuss the next steps of treatment. It made it a little more like a conversation. Dr. Gaffney made sure to ask if I had any questions several times, and he helped to facilitate my getting an appointment with another doctor sooner since I wasn't getting anywhere on my own.
UofU Patient
January 23, 2016
Again a scary situation made a little less scary
UofU Patient
January 17, 2016
I loved the PA and the doctor. Both were very friendly and understanding and answered my questions. I look forward to speaking with them again in the future when the time comes to do radiation treatments. I have full confidence in them. Thank you
UofU Patient
November 24, 2015
I believe Dr. Gaffney and the other providers really care and understand how devastated a new patient can feel. The fact that they would start my treatment immediately and not make me wait exceeded all my expectations. The medical student, Mona, spoke up and gave me information that helped me so much.
UofU Patient
October 17, 2015
Dr. Gaffney is a treasure.
UofU Patient
August 11, 2015
I felt that Dr. Gaffney and his resident Dr. cared about my situation and felt they helped me make a decision that would be best for my health and well being.
UofU Patient
August 07, 2015
Every step was thoughtfully explained to me. However, I was not prepared for the emotional impact of having the mold made for me. The passivity of my position with the emotional drama of having my breast drawn on and tattooed was intense. I am not sure what could have been done to minimize it, but it was emotionally challanging
UofU Patient
July 01, 2015
Drs Gaffney and Orton were very helpful with questions and answers. I fill like I'm in good hands.
UofU Patient
June 13, 2015
Dr. Gaffney has always been informative and supportive. He obviously knows what he is doing and he explains things clearly and carefully.
UofU Patient
May 27, 2015
good
UofU Patient
May 02, 2015
After a horrible experience with another doctor that day, I wasn't sure what I would be walking into here. I was surprised to be called back before we even got the paperwork finished. nurse Ruth was amazing! I was in a lot of pain when we got here, my first pelvic exam from another dr was rough and painful. Dr Gaffney was very kind and seemed to truly care about my situation. His exam was gentle and brief. then we moved to another room and sat down to discuss everything with us. answered my questions well and seemed to make us believe he had all the time in the world for us when in reality he is a busy man. I felt very well taken care of with Dr Gaffney!
UofU Patient
March 31, 2015
Best place in the world if you have to have cancer
UofU Patient
March 03, 2015
Dr Gaffney was easy to understand as he explained things to me and answered my questions.
UofU Patient
February 20, 2015
Dr Gaffney is always nice, very intelligent man!
UofU Patient
February 03, 2015
Gassney and Rosenthal provided great care.
UofU Patient
January 06, 2015
good
UofU Patient
December 06, 2014
The hospital has the most caring and wonderful doctors.
UofU Patient
October 11, 2014
It was a good experience.
UofU Patient
August 06, 2014
everyone i worked with at the huntsman was amazing. They were even nice and treated my husband well too. i would recommend them for sure and i would love to go back there if i had the chance to. hopefully not as a patience thou. cuz cancer isn't really fun at all
UofU Patient
July 18, 2014
Dr Gaffney has a very good personality and I enjoy his pleasant attitude.
UofU Patient
July 05, 2014
Dr. Gaffney is always great,very knowledgeable and kind. The questions that the doctor that came in first asked gave me pause. He asked if I had my mammogram that day when I've had a double mastectomy. I wasn't reassured at all. Thank goodness Dr. Gaffney came in!
UofU Patient
June 14, 2014
Dr. Gaffney and Dr. Williams always seem genuinely interested and concerned, as well as very competent, and they make me feel like they have plenty of time to spend with me. I appreciate this very much.
UofU Patient
May 31, 2014
I needed an ultrasound of my breast in addition to my mammogram and I didn't have to wait long. The radiology fellow was very good, professional and kind. The radiologist was also very good, but waited until 10 minutes into our conversation to report to me that my mammogram looked clear and that they were looking for a benign papilloma in my milk ducts; that information would have been a great way to start our conversation.
UofU Patient
May 15, 2014
I have already recommended Dr. Gaffney to others.
UofU Patient
March 28, 2014
posed for photos with patient even!
UofU Patient
February 14, 2014
The best
UofU Patient
January 31, 2014
Good
UofU Patient
January 25, 2014
This was an annual checkup. No insight given for continuing pain at incision sites.
UofU Patient
January 18, 2014
definitely recommend this place
UofU Patient
January 16, 2014
I have always found Dr. Gaffney to be a very caring person about me personally. He puts me at ease and makes me feel like I am a person to him and not just a name on a chart.
UofU Patient
September 30, 2013
I love everyone who has ever seen me in my 3 1/2 years of going to the Huntsmans.
UofU Patient
September 26, 2013
I have felt very good about my experiences at the Huntsman and that I have received the best care and concern.
UofU Patient
September 20, 2013
Every person who has seen me at Huntsman Cancer Institute has been professional, forthcoming with information, kind as an angel and concerned about me individually. I've never experienced such loving care for anything in my life. If I could, I'd live in a back room at Huntsman and come out every morning to soak up the healing, positive energy I feel within the building itself and from the wonderful people and facilities. I have to go back to Arizona where I live but I am looking forward to my three month visits at Huntsman with Dr. Gaffney, Dr. Soisson and RN Colleen, and the rest of the dear staff. If I could only sit in the lobby and hear the pianist I feel I'd be well and wise in no time. Please thank him for his generosity of time and talent. I listen to him for as long as he plays everytime.
UofU Patient
April 29, 2013
In that my appt was changed at my request and squeezed into the morning schedule, I was amazed at the unhurried time I felt I had with the nurse, resident and doctor. Thank you.
UofU Patient
April 29, 2013
care provider staff was very professional.
UofU Patient
April 25, 2013
Dr. Gaffney is extremely easy to talk with and his positive attitude makes the entire process easy and comfortable.
UofU Patient
April 08, 2013
I liked the fact that Dr. Gaffney came in personally, and did the followup check. He was personable and informative, as he always is.
UofU Patient
March 26, 2013
Dr. Gaffney has always been very informative and clear on every step. I have full faith and confidence in his ability.
UofU Patient
March 05, 2013
Everyone was very nice and compassionate with my situation.
UofU Patient
March 04, 2013
I already have recommended Dr. Gaffney to another friend who has just been dx'd with breast cancer.
UofU Patient
January 21, 2013
Dr. Gaffney was awesome...my husband and I are not neophytes in regards to health care and my diagnosis. He treated us with respect and intelligence.
UofU Patient
January 21, 2013
Everyone was spookier friendly!
UofU Patient
December 06, 2012
Dr. Gaffney is a good listener and very nice! Very smart also. Dr. Wagner is also very good.
UofU Patient
September 10, 2012
Dr. Gaffney maintained eye contact for several seconds after the exam and before he left. I felt like a human being to him
David Gaffney, MD, PhD, is vice-chair and professor of radiation oncology at the University of Utah School of Medicine and Huntsman Cancer Institute. He is an HCI investigator and member of the Experimental Therapeutics program. His primary clinical interests are in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma. His main research interests are in clinical trial development, prognostic markers, and secondary cancers.
Dr. Gaffney is interested in clinical trials that improve survival and quality of life for cancer patients. He serves as chair of the Gynecologic Working Group for the Radiation Therapy Oncology Group (RTOG). The RTOG is a multi-institutional cooperative cancer research organization that conducts clinical trials. He is active in the Gynecologic Cancer Intergroup (a worldwide organization of clinical trial groups). He serves on a National Cancer Institute panel evaluating gynecologic clinical trials. Dr. Gaffney is the chair of the Clinical Cancer Investigation Committee at the University of Utah and Huntsman Cancer Institute. He serves as a Senior Editor for the International Journal of Gynecologic Cancer, and he is a member of multiple professional societies.
In addition, Dr. Gaffney is interested in radiation sensitizers, which are drugs that make cancer cells more sensitive to the effects of radiation therapy. Dr. Gaffney enjoys working with medical students and residents on a wide variety of projects.
Dr. Gaffney received his PhD in biochemistry from the Medical College of Wisconsin in 1990 and his MD from the same institution in 1992. He completed an internship at LDS Hospital in Salt Lake City, Utah, and a residency in radiation oncology at the University of Utah School of Medicine.
David Gaffney, MD, PhD, is vice-chair and professor of radiation oncology and Senior Director for Clinical Research at the Huntsman Cancer Institute. His main research interests are in clinical trial development, prognostic markers, radiation sensitizers, and secondary cancers. He is an active clinician and specializes in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma.
Dr. Gaffney is interested in clinical trials that improve survival and quality of life for cancer patients. He serves as a co-Chair for the National Cancer Institute Gynecologic Cancer Steering Committee and previously was chair of the Gynecologic Working Group for the Radiation Therapy Oncology Group (RTOG). He is a past chair of the American Brachytherapy Society and the Cervix Cancer Research Network. He is active in the Gynecologic Cancer Intergroup, a worldwide organization of clinical trial groups. He also chairs the Clinical Research Executive Committee at the Huntsman Cancer Institute and serves as a Senior Editor for the International Journal of Gynecologic Cancer, Gynecologic Oncology, and the American Journal of Clinical Oncology, and Brachytherapy.
In addition, Dr. Gaffney is interested in radiation sensitizers, which are drugs that make cancer cells more sensitive to the effects of radiation therapy. Dr. Gaffney enjoys working with medical students and residents on a wide variety of projects.
Dr. Gaffney received his PhD in biochemistry from the Medical College of Wisconsin in 1990 and his MD from the same institution in 1992. He completed an internship at LDS Hospital in Salt Lake City, Utah, and a residency in radiation oncology at the University of Utah School of Medicine.
Academic Locations
Huntsman Cancer Hospital
801-581-2396
Board Certification and Academic Information
| Academic Departments | Radiation Oncology
-
Professor |
| Board Certification | American Board of Radiology (Radiation Oncology) |
| Cancer Center Programs | Experimental Therapeutics |
Research Interests
- Gynecologic Oncology
- Breast Cancer
- Lymphoma
- Secondary Cancer Risk
- Prognostic Markers
- Clinical Trial Development
Education History
| Residency | University of Utah Radiation Oncology Resident |
| Internship | LDS Hospital Intern |
| Professional Medical | Medical College of Wisconsin Medicine M.D. |
| Doctoral Training | Medical College of Wisconsin Biochemistry Ph.D. |
| Undergraduate | University of Colorado Chemistry B.A. |
Selected Publications - Journal Articles
Journal Article
- Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, Erickson B, Fyles A, Goulart J, Harkenrider M, Jhingran A, Klopp A, Koh WJ, Lim K, Petersen I, Portelance L, Small W Jr, Stewart A, Wiebe E, Wolfson A, Yashar C, Bosch W (2016 Jul 15). Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. Int J Radiat Oncol Biol Phys, 95(4), 1191-200.
- Orton A, Boothe D, Williams N, Buchmiller T, Huang YJ, Suneja G, Poppe M, Gaffney D (2016 Jun). Brachytherapy improves survival in primary vaginal cancer. Gynecol Oncol, 141(3), 501-506.
- Boothe D, Orton A, Odei B, Stoddard G, Suneja G, Poppe MM, Werner TL, Gaffney DK (2016 Jun). Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival. Gynecol Oncol, 141(3), 421-427.
- Sagae S, Monk BJ, Pujade-Lauraine E, Gaffney DK, Narayan K, Ryu SY, McCormack M, Plante M, Casado A, Reuss A, Chavez-Blanco A, Kitchener H, Nam BH, Jhingran A, Temkin S, Mileshkin L, Berns E, Scholl S, Doll C, Abu-Rustum NR, Lecuru F, Small W Jr (2016 Jan). Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future. Int J Gynecol Cancer, 26(1), 199-207.
- Ahmed F, Sarkar V, Gaffney DK, Salter B, Poppe MM (2016 Autumn). Analysis of nodal coverage utilizing image guided radiation therapy for primary gynecologic tumor volumes. Med Dosim, 41(3), 195-8.
- Frandsen J, Ly D, Cannon G, Suneja G, Matsen C, Gaffney DK, Wright M, Kokeny KE, Poppe MM (2015 Dec 1). In the Modern Treatment Era, Is Breast Conservation Equivalent to Mastectomy in Women Younger Than 40 Years of Age? A Multi-Institution Study. Int J Radiat Oncol Biol Phys, 93(5), 1096-103.
- Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Valea FA, Yashar CM, McMillian NR, Scavone JL (2015 Nov). Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines. J Natl Compr Canc Netw, 13(11), 1321-31.
- Jolly S, Soni P, Gaffney DK, Biagioli M, Elshaikh MA, Jhingran A, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Wahl AO, Williams NL, Yashar CM, Small W Jr (2015 Nov). ACR Appropriateness Criteria(R) Adjuvant Therapy in Vulvar Cancer. Oncology (Williston Park), 29(11), 867-72, 874-5.
- Lim K, Erickson B, Jurgenliemk-Schulz IM, Gaffney D, Creutzberg CL, Viswanathan A, Portelance L, Beriwal S, Wolfson A, Bosch W, De Los Santos J, Yashar C, Jhingran A, Varia M, El Naqa I, King B, Fyles A (2015 Nov-Dec). Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios. Pract Radiat Oncol, 5(6), e557-65.
- Frandsen J, Boothe D, Gaffney DK, Wilson BD, Lloyd S (2015 Oct). Increased risk of death due to heart disease after radiotherapy for esophageal cancer. J Gastrointest Oncol, 6(5), 516-23.
- Schwarz JK, Beriwal S, Esthappan J, Erickson B, Feltmate C, Fyles A, Gaffney D, Jones E, Klopp A, Small W Jr, Thomadsen B, Yashar C, Viswanathan A (2015 Sep-Oct). Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. Brachytherapy, 14(5), 587-99.
- Ly D, Soisson PA, Dodson MK, Sause WT, Gaffney DK (2015 Sep). Adjuvant radiation therapy is associated with improved pelvic control and overall survival in FIGO IB endometrial carcinoma with high grade histology. Gynecol Oncol, 138(3), 526-31.
- Bagshaw HP, Williams NL, Huang YJ, Tward JD, Gaffney DK (2015 Aug). Palladium interstitial implant in combination with external beam radiotherapy and chemotherapy for the definitive treatment of a female urethral carcinoma. Gynecol Oncol Rep, 13, 40-3.
- Gaffney DK, Suneja G, Ryu SY, McCormick M, Plante M, Mileshkin L, Small W Jr, Bacon M, Stuart G, Kitchener H (2015 Jul 1). The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroup. Int J Radiat Oncol Biol Phys, 92(3), 506-8.
- Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W Jr, Gaffney DK (2015 Jul 1). NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. Cancer, 121(13), 2156-63.
- Lum MM, Belnap TW, Frandsen J, Brown AP, Sause WT, Soisson AP, Dodson MK, Werner T, Gaffney DK (2015 Jun). Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer. Am J Clin Oncol, 38(3), 283-8.
- Williams NL, Werner TL, Jarboe EA, Gaffney DK (2015 Apr). Adenocarcinoma of the cervix: should we treat it differently? Curr Oncol Rep, 17(4), 17.
- Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, Chu C, Cohn D, Crispens MA, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR 3rd, Mutch D, Fader AN, Remmenga SW, Reynolds RK, Teng N, Tillmanns T, Valea FA, Yashar CM, McMillian NR, Scavone JL (2015 Apr). Cervical Cancer, Version 2.2015. J Natl Compr Canc Netw, 13(4), 395-404; quiz 404.
- Nickman NA, Ye X, Gaffney DK, Barney RB, Biskupiak JE, Okano GJ, Lee VC, Arellano J (2015 Mar). Cost of palliative external beam radiotherapy (EBRT) use for bone metastases secondary to prostate cancer. J Community Support Oncol, 13(3), 95-103.
- Chen LA, Kim J, Boucher K, Terakedis B, Williams B, Nickman NA, Gaffney DK (2015 Mar). Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers. Gynecol Oncol, 136(3), 521-8.
- Suneja G, Bacon M, Small W Jr, Ryu SY, Kitchener HC, Gaffney DK (2015). The cervix cancer research network: increasing access to cancer clinical trials in low- and middle-income countries. Front Oncol, 5, 14.
- Bagshaw HP, Pappas LM, Kepka DL, Tward JD, Gaffney DK (2014 Nov). Patterns of care with brachytherapy for cervical cancer. Int J Gynecol Cancer, 24(9), 1659-64.
- Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O 3rd, DSouza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W Jr, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W (2014 Oct 1). Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys, 90(2), 320-8.
- Elshaikh MA, Yashar CM, Wolfson AH, Cardenes HR, Erickson B, Jhingran A, Jolly S, Kidd E, Lee LJ, Mayr NA, Moore D, Rao GG, Small W Jr, Varia MA, Wahl AO, Yuh W, Gaffney DK (2014 Aug). ACR appropriateness Criteria(R) advanced stage endometrial cancer. Am J Clin Oncol, 37(4), 391-6.
- Gaffney DK, Jhingran A, Portelance L, Viswanathan A, Schefter T, Weidhaas J, Small W Jr (2014 Jun). Radiation therapy oncology group gynecologic oncology working group: comprehensive results. Int J Gynecol Cancer, 24(5), 956-62.
- Ly D, Rowley BD, Dodson MK, Soisson PA, Jolles CJ, Gaffney DK, Sause WT (2014 May). Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival. Gynecol Oncol, 133(2), 250-5.
- Nicholas Z, Hu N, Ying J, Soisson P, Dodson M, Gaffney DK (2014 Apr). Impact of comorbid conditions on survival in endometrial cancer. Am J Clin Oncol, 37(2), 131-4.
- Frandsen JE, Sause WT, Dodson MK, Soisson AP, Belnap TW, Gaffney DK (2014 Apr). Survival analysis of endometrial cancer patients with cervical stromal involvement. J Gynecol Oncol, 25(2), 105-10.
- Lalwani N, Dubinsky T, Javitt MC, Gaffney DK, Glanc P, Elshaikh MA, Kim YB, Lee LJ, Pannu HK, Royal HD, Shipp TD, Siegel CL, Simpson L, Wahl AO, Wolfson AH, Zelop CM (2014 Mar). ACR Appropriateness Criteria(R) pretreatment evaluation and follow-up of endometrial cancer. Ultrasound Q, 30(1), 21-8.
- Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Cohn D, Crispens MA, Dupont N, Eifel PJ, Fader AN, Fisher CM, Gaffney DK, George S, Han E, Huh WK, Lurain JR 3rd, Martin L, Mutch D, Remmenga SW, Reynolds RK, Small W Jr, Teng N, Tillmanns T, Valea FA, McMillian N, Hughes M (2014 Feb). Uterine neoplasms, version 1.2014. J Natl Compr Canc Netw, 12(2), 248-80.
- Cho S, Sun Y, Jarboe EA, Soisson AP, Dodson MK, Gaffney DK, Peterson CM, Janat-Amsbury MM (2013 Dec 15). Mucoadhesive hybrid gel improves intraperitoneal platinum delivery. Int J Pharm, 458(1), 148-55.
- Anker CJ, ODonnell K, Boucher KM, Gaffney DK (2013 Winter). Effect of brachytherapy technique and patient characteristics on cervical cancer implant dosimetry. Med Dosim, 38(4), 430-5.
- Page, BR, Belnap, TR, Bowen, RC, Gaffney, DK, Sause, WT (). Utilization of Hypofractionated and Conventional Breast Radiotherapy in the State of Utah. Cancer Clin Oncol, 2(2), 34-41.
- Wagner AE, Wada D, Bowen G, Gaffney DK (2013 Sep). Mycosis fungoides: the addition of concurrent and adjuvant interferon to total skin electron beam therapy. Br J Dermatol, 169(3), 715-8.
- Cai B, Nickman NA, Gaffney DK (2013 Sep). The cost-effectiveness of external beam radiation therapy in bone metastases. Curr Opin Support Palliat Care, 7(3), 278-83.
- Young J, Nickman NA, Biskupiak JE, Barney RB, Gaffney DK, Namjoshi M, Brandt P (2013 Aug). Characterization of clinical course and usual care patterns in female metastatic breast cancer patients treated with zoledronic acid. Utah's Health: An Annual Review, 22(4), 495-503.
- Wagner AE, Pappas L, Ghia AJ, Gaffney DK (2013 Jun). Impact of tumor size on survival in cancer of the cervix and validation of stage IIA1 and IIA2 subdivisions. Gynecol Oncol, 129(3), 517-21.
- Brown AP, Gaffney DK, Dodson MK, Soisson AP, Belnap TW, Alleman K, Sause WT (2013 Jun). Survival analysis of endometrial cancer patients with positive lymph nodes. Int J Gynecol Cancer, 23(5), 861-8.
- Kunos CA, Winter K, Dicker AP, Small W Jr, Abdul-Karim FW, Dawson D, Jhingran A, Valicenti R, Weidhaas JB, Gaffney DK (2013 May). Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis. Int J Gynecol Cancer, 23(4), 615-21.
- Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Cohn D, Crispens MA, DuPont N, Eifel PJ, Gaffney DK, Giuntoli RL 2nd, Han E, Huh WK, Lurain JR 3rd, Martin L, Morgan MA, Mutch D, Remmenga SW, Reynolds RK, Small W Jr, Teng N, Tillmanns T, Valea FA, McMillian NR, Hughes M (2013 Mar 1). Cervical cancer. J Natl Compr Canc Netw, 11(3), 320-43.
- Cai B, Nickman NA, Gaffney DK (2013 Mar). The role of palliative external beam radiation therapy in boney metastases pain management. J Pain Palliat Care Pharmacother, 27(1), 28-34.
- Doll CM, Winter K, Gaffney DK, Ryu JK, Jhingran A, Dicker AP, Weidhaas JB, Miller BE, Magliocco AM (2013 Jan). COX-2 expression and survival in patients with locally advanced cervical cancer treated with chemoradiotherapy and celecoxib: a quantitative immunohistochemical analysis of RTOG C0128. Int J Gynecol Cancer, 23(1), 176-83.
- Lindsay R, Paul J, Siddiqui N, Davis J, Gaffney DK (2012 Nov). Survey on the management of early cervical cancer among members of the GCIG. Int J Gynecol Cancer, 22(9), 1617-23.
- Gaffney DK (2012 Oct). Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy? J Gynecol Oncol, 23(4), 207-9.
- Jhingran A, Winter K, Portelance L, Miller B, Salehpour M, Gaur R, Souhami L, Small W Jr, Berk L, Gaffney D (2012 Sep 1). A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418. Int J Radiat Oncol Biol Phys, 84(1), e23-8.
- Small W Jr, Strauss JB, Jhingran A, Yashar CM, Cardenes HR, Erickson-Wittmann BA, Gullett N, Kidd E, Lee LJ, Mayr NA, Moore D, Puthawala AA, Rao GG, Varia MA, Wahl AO, Wolfson AH, Yuh W, Gaffney DK (2012 Aug). ACR Appropriateness Criteria(R) definitive therapy for early-stage cervical cancer. Am J Clin Oncol, 35(4), 399-405.
- Schefter TE, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W Jr, Gaffney DK (2012 Jul 15). A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417. Int J Radiat Oncol Biol Phys, 83(4), 1179-84.
- Hymas RV, Gaffney DK, Parkinson BT, Belnap TW, Sause WT (2012 Jun 1). Is short-interval mammography necessary after breast conservation surgery and radiation treatment in breast cancer patients? Int J Radiat Oncol Biol Phys, 83(2), 519-24.
- Siegel CL, Andreotti RF, Cardenes HR, Brown DL, Gaffney DK, Horowitz NS, Javitt MC, Lee SI, Mitchell DG, Moore DH, Rao GG, Royal HD, Small W Jr, Varia MA, Yashar CM (2012 Jun). ACR Appropriateness Criteria(R) pretreatment planning of invasive cancer of the cervix. J Am Coll Radiol, 9(6), 395-402.
- Page BR, Pappas L, Cooke EW, Gaffney DK (2012 May). Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology. Int J Gynecol Cancer, 22(4), 593-8.
- Gaffney D, Mundt A, Schwarz J, Eifel P (2012 May). Advances in clinical research in gynecologic radiation oncology: an RTOG symposium. Int J Gynecol Cancer, 22(4), 667-74.
- Citrin DE, Hitchcock YJ, Chung EJ, Frandsen J, Urick ME, Shield W, Gaffney D (2012 Apr 26). Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies. Radiat Oncol, 7(1), 64.
- Wolfson AH, Varia MA, Moore D, Rao GG, Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Small W Jr, Yashar CM, Yuh W, Cardenes HR (2012 Apr). ACR Appropriateness Criteria(R) role of adjuvant therapy in the management of early stage cervical cancer. Gynecol Oncol, 125(1), 256-62.
- Viswanathan AN, Thomadsen B (). American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy, 11(1), 33-46.
- Gaffney DK, Werner TL (). Curative Treatment for Recurrent and Metastatic Cervix Cancer? Expert Rev Obstet Gynecol, 7(6), 521-523.
- Small W Jr, Beriwal S, Demanes DJ, Dusenbery KE, Eifel P, Erickson B, Jones E, Rownd JJ, De Los Santos JF, Viswanathan AN, Gaffney D (2012 Jan-Feb). American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy, 11(1), 58-67.
- Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, Jones E, Kirisits C, Thomadsen B, Erickson B (2012 Jan-Feb). American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy, 11(1), 47-52.
- Viswanathan AN, Moughan J, Small W Jr, Levenback C, Iyer R, Hymes S, Dicker AP, Miller B, Erickson B, Gaffney DK (2012 Jan). The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. Int J Gynecol Cancer, 22(1), 123-31.
- Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Moore D, Rao GG, Small W Jr, Varia MA, Wolfson AH, Yashar CM, Yuh W, Cardenes HR (2011 Nov 1). ACR Appropriateness Criteria(R) on Advanced Cervical Cancer Expert Panel on Radiation Oncology-Gynecology. Int J Radiat Oncol Biol Phys, 81(3), 609-14.
- Cooke EW, Pappas L, Gaffney DK (). Does the Revised International Federation of Gynecology and Obstetrics Staging System for Endometrial Cancer Lead to Increased Discrimination in Patient Outcomes? Cancer, 117(18), 4231-4239.
- Lee JH, Dubinsky T, Andreotti RF, Cardenes HR, Dejesus Allison SO, Gaffney DK, Glanc P, Horowitz NS, Jhingran A, Lee SI, Puthawala AA, Royal HD, Scoutt LM, Small W Jr, Varia MA, Zelop CM (2011 Jun). ACR appropriateness Criteria(R) pretreatment evaluation and follow-up of endometrial cancer of the uterus. Ultrasound Q, 27(2), 139-45.
- Ghia AJ, Gonzalez VJ, Tward JD, Stroup AM, Pappas L, Gaffney DK (2011 Feb). Primary vaginal cancer and chemoradiotherapy: a patterns-of-care analysis. Int J Gynecol Cancer, 21(2), 378-84.
Review
- Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, Mayr NA, Moore D, Puthawala AA, Rao GG, Small W Jr, Varia MA, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Gaffney DK (2013 Nov). Acr appropriateness Criteria management of vaginal cancer. [Review]. Oncology (Williston Park), 27(11), 1166-73.
- Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W Jr, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes HR (2013 Aug). ACR Appropriateness Criteria(R) management of locoregionally advanced squamous cell carcinoma of the vulva. [Review]. Am J Clin Oncol, 36(4), 415-22.
Book
- David K Gaffney, Dennis C Shrieve, Christopher J Anker, Mark K Buyyounouski, Feng-Ming Kong, Ying J Hitchcock, Jonathan D Tward (). Radiation Oncology: Imaging and Treatment. Amirsys.
Book Chapter
- Boothe D, Gaffney DK (). Radiotherapy for Vulvar Cancers. In Ali Ayhan, Nicholas Reed, Murat Gultekin, Polat Dursun (Eds.), Textbook of Gynaecological Oncology (Second). Istanbul: Gunes Publishing.
- Orton AW, Gaffney DK (). Radiotherapy for Vaginal Cancers. In Ali Ayhan, Nicholas Reed, Murat Gultekin, Polat Dursun (Eds.). (Eds.), Textbook of Gynaecological Oncology (Second). Istanbul:: Gunes Publishing.
- Jonathan D Tward, Christopher J Anker, David K Gaffney and Glen M Bowen (). Radiation Therapy and Skin Cancer. In Modern Practices in Radiation Therapy.
- Ghia A, Gaffney DK (). Radiotherapy for Vaginal and Vulvar Cancers. In Ali Ayhan, Nicholas Reed, Murat Gultekin, Polat Dursun (Eds.), Textbook of Gynaecological Oncology (First). Istanbul: Gunes Publishing.
- Mayer NA, Gaffney DK, Small Q (). Cervical Cancer (Ch. 22). In Liu JL, Brady LW (Eds.), Decision Making in Radiation Oncology (pp. 662-701). Springer.
- Anker CA, Gaffney DK (In Press). Ovary. In Shrieve DC, Loeffler J (Eds.), Human Radiation Injury (1st, pp. 365-384). Philadelphia: Lippencott Williams and Wilkins.
- Gonzalez VJ, Gaffney DK (In Press). Vagina. In Shrieve DC, Loeffler J (Eds.), Human Radiation Injury (1st, pp. 385-402). Philadelphia: Lippencott WIlliams and Wilkins.
Conference Proceedings
- David K Gaffney (). Radiotherapy in the management of gynecologic cancers. KGOG Symposium & Workshop.
Editorial
- Sharma DN, Gaffney DK (2016 Mar-Apr). Concurrent chemobrachytherapy in locally advanced cervical carcinoma: A hypothesis worth exploring. Brachytherapy, 15(2), 200-4.
- David Gaffney (). Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy? Journal of Gynecologic Oncology, 23(4), 207-210.
Abstract
- Viswanathan AN, Erickson B, Beriwal S, DSouza DP, Jones EL, Portelance L, Small W, Yashar CM, Gaffney DK (). Consensus Contours for CT versus MR in Image-Based Brachytherapy for Cervix Cancer to Generate an RTOG Atlas [Abstract]. International Journal of Radiation Oncology Biology and Physics, 87(2S), 330.